Achilles Therapeutics plc - 00449L102
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q4 2024
· Q3 2024
Value (USD)
Total reported value ($000)
$2.241M
QoQ value delta ($000)
+$296K
(+15.22%)
Implied price effect (QoQ)
+11.87%
Shares
Total shares
1,969,958
QoQ shares delta
+57,233
(+2.99%)
Total shares held by funds (by quarter)
Top holders (Q4 2024)
Top 25 only
Full list
Early Q1 2026 data: only 2 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Siren, L.L.C. | 861 | 755,375 | 0.04% |
| RENAISSANCE TECHNOLOGIES LLC | 623 | 547,233 | 0.0% |
| BOOTHBAY FUND MANAGEMENT, LLC | 477 | 418,441 | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 70 | 61,637 | 0.0% |
| BNP PARIBAS FINANCIAL MARKETS | 57 | 50,189 | 0.0% |
| MORGAN STANLEY | 38 | 33,731 | 0.0% |
| TWO SIGMA ADVISERS, LP | 38 | 34,200 | 0.0% |
| XTX Topco Ltd | 30 | 26,824 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 24 | 21,590 | 0.0% |
| CITADEL ADVISORS LLC | 18 | 15,799 | 0.0% |
| RHUMBLINE ADVISERS | 5 | 4,480 | 0.0% |
| JPMORGAN CHASE & CO | 0 | 137 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 322 | 0.0% |